Table 2.
FMFM scores of three groups after intervention
| FMFM-domain | Baseline | 3 months | 6 months | 12 months |
|---|---|---|---|---|
| BMMMSC group | ||||
| A | 9.88 ± 2.81 | 12.03 ± 2.48** | 15.00 ± 2.40** | 17.58 ± 2.41** |
| B | 10.15 ± 3.63 | 12.27 ± 3.28** | 15.64 ± 3.36** | 17.67 ± 3.49** |
| C | 7.24 ± 4.19 | 10.55 ± 4.62** | 13.70 ± 3.40** | 15.58 ± 4.47** |
| D | 6.36 ± 5.15 | 9.21 ± 6.20* | 12.76 ± 7.37** | 14.82 ± 7.10** |
| E | 6.82 ± 6.47 | 8.88 ± 8.29 | 12.67 ± 8.82* | 13.76 ± 8.76* |
| Total | 40.45 ± 18.31 | 52.94 ± 20.94** | 69.76 ± 21.67**△ | 79.39 ± 21.95**△ |
| BMMNC group | ||||
| A | 9.91 ± 2.85 | 10.47 ± 2.94* | 11.15 ± 3.02* | 11.94 ± 2.96* |
| B | 10.14 ± 3.52 | 11.06 ± 3.35 | 12.18 ± 3.41* | 12.68 ± 3.30* |
| C | 7.24 ± 4.11 | 7.88 ± 4.04 | 8.53 ± 4.03* | 9.38 ± 4.20* |
| D | 6.47 ± 4.91 | 6.85 ± 5.03 | 7.88 ± 5.25* | 8.94 ± 5.55* |
| E | 6.79 ± 6.23 | 7.76 ± 6.80 | 8.65 ± 7.03* | 9.65 ± 7.19* |
| Total | 40.56 ± 17.57 | 44.03 ± 17.99 | 48.38 ± 18.47* | 52.59 ± 18.89** |
| Control group | ||||
| A | 9.83 ± 2.86 | 10.31 ± 2.54* | 10.71 ± 2.67* | 11.11 ± 2.89* |
| B | 10.03 ± 3.68 | 10. 60 ± 3.99 | 11.03 ± 4.07 | 11.34 ± 4.01 |
| C | 7.26 ± 4.23 | 7.74 ± 4.56 | 7.94 ± 4.56 | 8.46 ± 4.13 |
| D | 6.46 ± 4.97 | 6.86 ± 4.95 | 7.26 ± 5.00 | 7.54 ± 5.12 |
| E | 6.86 ± 6.40 | 7.40 ± 6.63 | 7.83 ± 6.83 | 8.26 ± 6.96 |
| Total | 40.43 ± 15.88 | 42.91 ± 15.84 | 44.77 ± 16.27 | 46.71 ± 16.07* |
** Compared with scores before transplantation/Bobath therapy, P < 0.01
* Compared with scores before transplantation/Bobath therapy, P < 0.05
△ Compared with scores 3 month after transplantation, P < 0.05